Recruitment

Recruitment Status
Terminated
Estimated Enrollment
300

Summary

Conditions
Chronic Lymphoid Leukemia
Type
Interventional
Phase
Phase 3
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT01518959
Collaborators
Not Provided
Investigators
Principal Investigator: Istvan Takacs, MD, PhD Semmelweis University